Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

GlaxoSmithKline Extends Tender Offer For Genelabs

By Pharmaceutical Processing | December 15, 2008

NEW YORK (AP) — Drug developer GlaxoSmithKline said Monday it extended the tender offer for shares of biotechnology company Genelabs Technologies Inc. in order to meet the deal’s 90 percent requirement. In November, U.K.-based Glaxo said it would move ahead with a $1.30 per share tender, offer, worth about $57 million. It first announced plans to buy Redwood City, Calif.-based Genelabs in October, in part to add two developing hepatitis C treatments to its product pipeline. Genelabs board of directors has already unanimously recommended that shareholders tender their shares in the offer. Glaxo has about 35.1 million Genelabs shares, or about 79 percent of the outstanding stock. Also, there are notices of guaranteed delivery for about 1.4 million shares. The tender offer is conditioned on Glaxo obtaining 90 percent of Genelabs stock. The tender offer has been extended to Dec. 29. The company eliminated the alternative for notices of guaranteed deliveries as part of the extension.

Related Articles Read More >

Fujifilm Diosynth Technologies
Fujifilm to spend $1.6B to bolster cell culture manufacturing services
Wyzo
Wyzo high-speed pick-and-place sidebot wins design awards
Purdue University
Purdue University launches institute for advanced manufacturing of pharmaceuticals
Sanofi logo
Sanofi introduces its first digital accelerator 

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards